HHS Increases Civil Penalties Under Information Blocking Rule Amendment

The Department of Health and Human Services (HHS), Office of Inspector General (OIG), announced on June 27, 2023, an amendment to the civil money penalty (CMP) regulations under the Information Blocking Rule. This significant development, lodged on the OIG’s official website, incorporates new CMP authority and elevates the maximum penalties associated with specific CMP violations….

Read More

Court Ruling Bolsters Patent Protection for “Therapeutically Effective” Dose Claims in Medical Treatments

In a recent ruling by the U.S. Court of Appeals for the Federal Circuit, it has been determined that a claim to a treatment method for pulmonary hypertension cannot be invalidated for lacking enablement or written description. The case at hand is United Therapeutics Corporation v. Liquidia Technologies, Inc. The court declared that the claims,…

Read More

Navigating the Complex Landscape of State Privacy Laws: Entity-Level vs. Data-Level Exemptions

In a world where businesses generate and handle enormous volumes of data, privacy law compliance has become more critical than ever. This is especially true for companies operating in heavily regulated sectors such as financial services and healthcare. An ever-increasing complexity within the patchwork of state privacy laws has added another layer to this burgeoning…

Read More

Navigating HHS-OIG Information Blocking Enforcement: Avoiding Million-Dollar Penalties

The US Department of Health and Human Services Office of Inspector General (HHS-OIG) recently issued a final ruling implementing its mandate under the 21st Century Cures Act to investigate allegations of information blocking among health IT developers and health information networks/exchanges (HIN/HIEs). Violations of this prohibition can lead to penalties as steep as $1 million…

Read More

Strengthening Fair Market Value Defensibility in Healthcare Compensation Agreements

As legal practitioners in the global business arena, the analysis of Fair Market Value (FMV) is often an area demanding utmost attention and precision. FMV, predominantly an issue of significance in regulatory compliance and compensation agreements concerning the healthcare sector, prompts a meticulous investigation of its defensibility. The following discussion draws on Health Care Compliance…

Read More